Scholars Central

Research articlePublished 2014

New Perspectives in Cancer Therapy: The Biotin-Antitumor Molecule Conjugates

Authors: Giuseppe Tripodo, Delia Mandracchia, Simona Collina, Marta Rui, Daniela Rossi

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chemotherapy is still the first-line treatment of cancer, even if drugs currently used in therapy generally possess high toxicity and poor selectivity. In the last two decades several efforts have been made to overcome these drawbacks by specifically carrying anticancer drugs to the tumors. Among the different approaches, the so called vitaminmediated drug targeting has recently emerged as a novel and valuable strategy. Indeed, the linkage of cytotoxic drugs to selected vitamins, leading to vitamin-drug conjugates, would result in specifically delivering great amounts of the targeted drug at high doses to cancer cells. Among vitamins, biotin seems to be the most promising targeting agent. The aim of this review is to get an overview on recent success in the conjugation of biotin with molecules endowed with anticancer properties.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedicinal Chemistry
  • SubjectChemistry
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Giuseppe Tripodo”
  • BylineArticles whose byline prints “Delia Mandracchia”
  • BylineArticles whose byline prints “Simona Collina”
  • BylineArticles whose byline prints “Marta Rui”
  • BylineArticles whose byline prints “Daniela Rossi”